Edgewood Management - Q1 2023 holdings

Add to watchlist

$31.2 Billion is the total value of Edgewood Management's 83 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
CL  COLGATE PALMOLIVE CO$57,105,358
-4.6%
759,8850.0%0.18%
-14.1%
ABBV  ABBVIE INC$12,865,940
-1.4%
80,7300.0%0.04%
-10.9%
ABT  ABBOTT LABS$7,303,884
-7.8%
72,1300.0%0.02%
-17.9%
VRTX  VERTEX PHARMACEUTICALS INC$6,443,182
+9.1%
20,4500.0%0.02%0.0%
PLD  PROLOGIS INC.$5,773,732
+10.7%
46,2750.0%0.02%
-5.3%
PFE  PFIZER INC$3,464,369
-20.4%
84,9110.0%0.01%
-26.7%
JNJ  JOHNSON & JOHNSON$3,030,560
-12.3%
19,5520.0%0.01%
-16.7%
FB  META PLATFORMS INCcl a$2,839,996
+76.1%
13,4000.0%0.01%
+50.0%
JPM  JPMORGAN CHASE & CO$2,796,974
-2.8%
21,4640.0%0.01%
-10.0%
BMRN  BIOMARIN PHARMACEUTICAL INC$1,458,600
-6.0%
15,0000.0%0.01%
-16.7%
KO  COCA COLA CO$1,406,282
-2.5%
22,6710.0%0.01%0.0%
CSCO  CISCO SYS INC$1,489,472
+9.7%
28,4930.0%0.01%0.0%
PRTA  PROTHENA CORP PLC$1,166,188
-19.6%
24,0600.0%0.00%
-20.0%
BRKB  BERKSHIRE HATHAWAY INC DELcl b new$1,399,346
-0.0%
4,5320.0%0.00%
-20.0%
BK  BANK NEW YORK MELLON CORP$1,349,750
-0.2%
29,7040.0%0.00%
-20.0%
BRKA  BERKSHIRE HATHAWAY INC DELcl a$1,396,800
-0.7%
30.0%0.00%
-20.0%
PLTR  PALANTIR TECHNOLOGIES INCcl a$845,000
+31.6%
100,0000.0%0.00%
+50.0%
RPRX  ROYALTY PHARMA PLC$828,690
-8.8%
23,0000.0%0.00%0.0%
MRK  MERCK & CO INC$831,757
-4.1%
7,8180.0%0.00%0.0%
LAC  LITHIUM AMERS CORP NEW$979,200
+14.8%
45,0000.0%0.00%0.0%
FCX  FREEPORT-MCMORAN INCcl b$585,790
+7.7%
14,3190.0%0.00%0.0%
ETG  EATON VANCE TX ADV GLBL DIV$678,300
+7.0%
42,0000.0%0.00%0.0%
DUK  DUKE ENERGY CORP NEW$527,498
-6.3%
5,4680.0%0.00%0.0%
MCRB  SERES THERAPEUTICS INC$567,000
+1.2%
100,0000.0%0.00%0.0%
ARWR  ARROWHEAD PHARMACEUTICALS IN$482,600
-37.4%
19,0000.0%0.00%
-33.3%
AGIO  AGIOS PHARMACEUTICALS INC$689,100
-18.2%
30,0000.0%0.00%
-33.3%
VOD  VODAFONE GROUP PLC NEWsponsored adr$583,861
+9.1%
52,8860.0%0.00%0.0%
 SOMALOGIC INC$255,000
+1.6%
100,0000.0%0.00%0.0%
HD  HOME DEPOT INC$229,308
-6.6%
7770.0%0.00%0.0%
ARMP  ARMATA PHARMACEUTICALS INC$167,000
+34.7%
100,0000.0%0.00%–
VZ  VERIZON COMMUNICATIONS INC$329,709
-1.3%
8,4780.0%0.00%0.0%
 ANNALY CAPITAL MANAGEMENT IN$267,540
-9.3%
14,0000.0%0.00%0.0%
 WARNER BROS DISCOVERY INC$312,947
+59.3%
20,7250.0%0.00%0.0%
PG  PROCTER AND GAMBLE CO$327,118
-1.9%
2,2000.0%0.00%0.0%
BNY  BLACKROCK N Y MUN INCOME TRUsh ben int$468,000
+3.3%
45,0000.0%0.00%
-50.0%
AXLA  AXCELLA HEALTH INC$48,000
+46.6%
100,0000.0%0.00%–
 GINKGO BIOWORKS HOLDINGS INC*w exp 09/16/202$1,800
-10.0%
10,0000.0%0.00%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

About Edgewood Management

Edgewood Management is a privately owned investment management firm that was founded in 1974. The company is headquartered in New York City and manages over $20 billion in assets for its clients. The firm is known for its long-term investment approach and its focus on high-quality growth companies.

The company's investment philosophy is centered around investing in companies that have strong competitive advantages, high-quality management teams, and sustainable growth prospects. Edgewood Management's investment team is led by CEO and Chief Investment Officer, William C. Ruane, who has been with the firm since its inception. The team also includes several other experienced investment professionals who have a deep understanding of the markets and the companies in which they invest.

Edgewood Management's investment strategy has been successful over the years, with the firm consistently outperforming its benchmarks. The company's flagship fund, the Edgewood Growth Fund, has delivered an average annual return of over 15% since its inception in 1974. The fund has also been recognized by Morningstar as a top-performing fund in its category.

Overall, Edgewood Management is a well-respected investment management firm that has a long track record of success. The company's focus on high-quality growth companies and its experienced investment team make it a strong choice for investors who are looking for a long-term investment strategy.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC42Q3 20237.8%
ILLUMINA INC42Q3 20236.6%
AMAZON COM INC42Q3 20237.4%
AMERICAN TOWER CORP NEW42Q3 20236.4%
INTUITIVE SURGICAL INC42Q3 20236.3%
CME GROUP INC42Q3 20235.8%
GILEAD SCIENCES INC42Q3 20237.5%
APPLE INC42Q3 20234.7%
3M CO42Q3 20231.2%
COLGATE PALMOLIVE CO42Q3 20230.7%

View Edgewood Management's complete holdings history.

Latest significant ownerships (13-D/G)
Edgewood Management Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ALIGN TECHNOLOGY INCFebruary 14, 20233,409,1454.4%
ILLUMINA, INC.February 14, 20236,478,3704.1%
Snap IncFebruary 14, 202349,0000.0%
ALLIANCE DATA SYSTEMS CORPSold outFebruary 14, 201900.0%
IHS Inc.February 11, 20164,335,8636.5%
STRATASYS LTD.Sold outFebruary 11, 201600.0%
QUANTA SERVICES INCFebruary 09, 20119,790,2894.6%
COVANCE INCSold outSeptember 08, 201000.0%

View Edgewood Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2023-02-13

View Edgewood Management's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Edgewood Management's holdings

CSVXLS